OTC · Drug Manufacturers - Specialty & Generic

AusCann Group Holdings Ltd (ACNNF) Stock

$0.00 OTC: ACNNF Healthcare

AusCann Group Holdings Ltd currently has no significant operational activities. Historically, the company was dedicated to the research, development, and commercialization of diverse therapeutic products originating from cannabinoids.

Valuation

MetricValue
Price$0.00
Market Cap$1.67M
P/E Ratio-1.63
P/B Ratio0.24
P/S Ratio0.84
EPS (TTM)$-0.02
52-Week High$4.00
52-Week Low—
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-157.14%
ROA-157.14%
ROCE-19.23%
Gross Margin-50.00%
Operating Margin-50.00%
Net Margin-550.00%
Debt/Equity0.00
Current Ratio49.47

Annual Financials (USD)

Metric20192020202120222023
Revenue$1.0M$0$2.0M$2.0M$2.0M
Operating Profit$-6.0M$-8.0M$-10.0M$-7.0M$-1.0M
Net Profit$-8.0M$-7.0M$-9.0M$-26.0M$-11.0M
EPS$-0.02$-0.02$-0.02$-0.06$-0.02
Op Margin-968.8%-235143.6%-586.9%-456.3%-89.0%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$43.0M$35.0M$45.0M$18.0M$7.0M
Total Liabilities$1.0M$1.0M$1.0M$0$0
Cash$35.0M$19.0M$14.0M$6.0M$7.0M
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-5.0M$-11.0M$-7.0M$-3.0M$-3.0M
Investing Cash Flow$-16.0M$-11.0M$1.0M$-10.0M$5.0M
Financing Cash Flow$-2.0M$0$0$0$0
Net Cash Flow$22.0M$-16.0M$-5.0M$-8.0M$1.0M
Free Cash Flow$-12.0M$-16.0M$-7.0M$-3.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-3.96
FCF Yield-20.76%
Quick Ratio49.36
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CANBCan B Corp. $0.02 +16.18% -0.11 $1.49M 0.00%
CBDNFCBD Global Sciences Inc. $0.04 -2.67% -0.20 $2.07M 0.00%
CIMVFPideka Group Inc. $0.01 +0.00% -1.16 $2.51M 0.00%
ETRGFEntourage Health Corp. $0.00 — -0.03 $1.23M 0.00%
IWINFIrwin Naturals Inc. $0.50 +51.52% -0.18 $1.68M 0.00%

About AusCann Group Holdings Ltd

AusCann Group Holdings Ltd currently has no significant operational activities. Historically, the company was dedicated to the research, development, and commercialization of diverse therapeutic products originating from cannabinoids. Its corporate headquarters are located in West Perth, Australia.

AusCann Group Holdings Ltd (ACNNF) stock trades at $0.00 with a market capitalization of $1.67M. The stock is valued at a price-to-earnings (P/E) ratio of -1.63, price-to-book of 0.24, price-to-sales of 0.84.

On profitability, AusCann Group Holdings Ltd generates a return on equity (ROE) of -157.14%, return on capital employed of -19.23%, an operating margin of -50.00%, a net profit margin of -550.00%.

Official website: auscann.com.au

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides